Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Charmacy Pharmaceutical Co., Ltd. Class H ( (HK:2289) ) just unveiled an announcement.
Charmacy Pharmaceutical Co., Ltd. announced its unaudited consolidated interim results for the six months ended June 30, 2025. The company reported a decline in operating revenue by 8.18% to RMB 2,155,071,000 and a decrease in net profit attributable to shareholders by 18.72% to RMB 21,739,000 compared to the same period in 2024. This decline in financial performance reflects challenges in the market and may impact the company’s positioning and stakeholder interests.
More about Charmacy Pharmaceutical Co., Ltd. Class H
Charmacy Pharmaceutical Co., Ltd. is a joint stock limited liability company incorporated in the People’s Republic of China, operating in the pharmaceutical industry. The company is listed on the Hong Kong Stock Exchange and focuses on providing pharmaceutical products and services.
Average Trading Volume: 42,140
Technical Sentiment Signal: Sell
Current Market Cap: HK$629.6M
Find detailed analytics on 2289 stock on TipRanks’ Stock Analysis page.